Literature DB >> 20090673

Serotonin transporter genotype and action monitoring dysfunction: a possible substrate underlying increased vulnerability to depression.

Avram J Holmes1, Ryan Bogdan, Diego A Pizzagalli.   

Abstract

A variable number of tandem repeats (short (S) vs long (L)) in the promoter region of the serotonin transporter gene (5-HTTLPR) and a functional variant of a single-nucleotide polymorphism (rs25531) in 5-HTTLPR have been recently associated with increased risk for major depressive disorder (MDD). In particular, relative to L/L or L(A) homozygotes (hereafter referred to as L' participants), S carriers or L(g)-allele carriers (S' participants) have been found to have a higher probability of developing depression after stressful life events, although inconsistencies abound. Previous research indicates that patients with MDD are characterized by executive dysfunction and abnormal activation within the anterior cingulate cortex (ACC), particularly in situations requiring adaptive behavioral adjustments following errors and response conflict (action monitoring). The goal of this study was to test whether psychiatrically healthy S' participants would show abnormalities similar to those of MDD subjects. To this end, 19 S' and 14 L' participants performed a modified Flanker task known to induce errors, response conflict, and activations in various ACC subdivisions during functional magnetic resonance imaging. As hypothesized, relative to L' participants, S' participants showed (1) impaired post-error and post-conflict behavioral adjustments; (2) larger error-related rostral ACC activation; and (3) lower conflict-related dorsal ACC activation. As similar behavioral and neural dysfunctions have been recently described in MDD patient samples, the current results raise the possibility that impaired action monitoring and associated ACC dysregulation may represent risk factors increased vulnerability to depression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20090673      PMCID: PMC2840070          DOI: 10.1038/npp.2009.223

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  81 in total

1.  Explicit and implicit neural mechanisms for processing of social information from facial expressions: a functional magnetic resonance imaging study.

Authors:  H Critchley; E Daly; M Phillips; M Brammer; E Bullmore; S Williams; T Van Amelsvoort; D Robertson; A David; D Murphy
Journal:  Hum Brain Mapp       Date:  2000-02       Impact factor: 5.038

2.  Error-related ERP components and individual differences in punishment and reward sensitivity.

Authors:  Maarten A S Boksem; Mattie Tops; Anne E Wester; Theo F Meijman; Monicque M Lorist
Journal:  Brain Res       Date:  2006-06-19       Impact factor: 3.252

3.  Blunted left cingulate activation in mood disorder subjects during a response interference task (the Stroop).

Authors:  M S George; T A Ketter; P I Parekh; N Rosinsky; H A Ring; P J Pazzaglia; L B Marangell; A M Callahan; R M Post
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1997       Impact factor: 2.198

4.  Depression and the magnification of failure.

Authors:  R M Wenzlaff; S A Grozier
Journal:  J Abnorm Psychol       Date:  1988-02

5.  An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk.

Authors:  Xianzhang Hu; Gabor Oroszi; Jeffrey Chun; Tom L Smith; David Goldman; Marc A Schuckit
Journal:  Alcohol Clin Exp Res       Date:  2005-01       Impact factor: 3.455

6.  A global measure of perceived stress.

Authors:  S Cohen; T Kamarck; R Mermelstein
Journal:  J Health Soc Behav       Date:  1983-12

Review 7.  Neuroimaging studies of serotonin gene polymorphisms: exploring the interplay of genes, brain, and behavior.

Authors:  Sarah M Brown; Ahmad R Hariri
Journal:  Cogn Affect Behav Neurosci       Date:  2006-03       Impact factor: 3.282

8.  Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Authors:  Avshalom Caspi; Karen Sugden; Terrie E Moffitt; Alan Taylor; Ian W Craig; HonaLee Harrington; Joseph McClay; Jonathan Mill; Judy Martin; Antony Braithwaite; Richie Poulton
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

9.  Serotonin transporter genetic variation and the response of the human amygdala.

Authors:  Ahmad R Hariri; Venkata S Mattay; Alessandro Tessitore; Bhaskar Kolachana; Francesco Fera; David Goldman; Michael F Egan; Daniel R Weinberger
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

10.  Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed.

Authors:  B C Beats; B J Sahakian; R Levy
Journal:  Psychol Med       Date:  1996-05       Impact factor: 7.723

View more
  24 in total

Review 1.  Frontocingulate dysfunction in depression: toward biomarkers of treatment response.

Authors:  Diego A Pizzagalli
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

2.  Monoaminergic modulation of behavioural and electrophysiological indices of error processing.

Authors:  Jessica J M Barnes; Redmond G O'Connell; L Sanjay Nandam; Angela J Dean; Mark A Bellgrove
Journal:  Psychopharmacology (Berl)       Date:  2013-08-31       Impact factor: 4.530

3.  A computational analysis of flanker interference in depression.

Authors:  D G Dillon; T Wiecki; P Pechtel; C Webb; F Goer; L Murray; M Trivedi; M Fava; P J McGrath; M Weissman; R Parsey; B Kurian; P Adams; T Carmody; S Weyandt; K Shores-Wilson; M Toups; M McInnis; M A Oquendo; C Cusin; P Deldin; G Bruder; D A Pizzagalli
Journal:  Psychol Med       Date:  2015-03-02       Impact factor: 7.723

4.  Reduced gray matter volume in the anterior cingulate, orbitofrontal cortex and thalamus as a function of mild depressive symptoms: a voxel-based morphometric analysis.

Authors:  C A Webb; M Weber; E A Mundy; W D S Killgore
Journal:  Psychol Med       Date:  2014-02-26       Impact factor: 7.723

5.  Neural responses to negative feedback are related to negative emotionality in healthy adults.

Authors:  Diane L Santesso; Ryan Bogdan; Jeffrey L Birk; Elena L Goetz; Avram J Holmes; Diego A Pizzagalli
Journal:  Soc Cogn Affect Neurosci       Date:  2011-09-14       Impact factor: 3.436

Review 6.  Sex differences modulating serotonergic polymorphisms implicated in the mechanistic pathways of risk for depression and related disorders.

Authors:  LeeAnn M Perry; Andrea N Goldstein-Piekarski; Leanne M Williams
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

7.  Neural Correlates of Three Promising Endophenotypes of Depression: Evidence from the EMBARC Study.

Authors:  Christian A Webb; Daniel G Dillon; Pia Pechtel; Franziska K Goer; Laura Murray; Quentin J M Huys; Maurizio Fava; Patrick J McGrath; Myrna Weissman; Ramin Parsey; Benji T Kurian; Phillip Adams; Sarah Weyandt; Joseph M Trombello; Bruce Grannemann; Crystal M Cooper; Patricia Deldin; Craig Tenke; Madhukar Trivedi; Gerard Bruder; Diego A Pizzagalli
Journal:  Neuropsychopharmacology       Date:  2015-06-12       Impact factor: 7.853

8.  Decreased cognitive control in response to negative information in patients with remitted depression: an event-related potential study.

Authors:  Marie-Anne Vanderhasselt; Rudi De Raedt; Daniel G Dillon; Sunny J Dutra; Nancy Brooks; Diego A Pizzagalli
Journal:  J Psychiatry Neurosci       Date:  2012-07       Impact factor: 6.186

9.  The impact of serotonin transporter (5-HTTLPR) genotype on the development of resting-state functional connectivity in children and adolescents: a preliminary report.

Authors:  Jillian Lee Wiggins; Jirair K Bedoyan; Scott J Peltier; Samantha Ashinoff; Melisa Carrasco; Shih-Jen Weng; Robert C Welsh; Donna M Martin; Christopher S Monk
Journal:  Neuroimage       Date:  2011-10-18       Impact factor: 6.556

10.  Behavioral and electrophysiological correlates of training-induced cognitive control improvements.

Authors:  Alexander J Millner; Adam C Jaroszewski; Harish Chamarthi; Diego A Pizzagalli
Journal:  Neuroimage       Date:  2012-07-23       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.